✦ LIBER ✦

Impact of Cytomegalovirus Disease in D+/R– Kidney Transplant Patients Receiving 6 Months Low-Dose Valganciclovir Prophylaxis

✍ Scribed by F. L. Luan; M. Kommareddi; A. O. Ojo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Six-Month Low-Dose Valganciclovir Prophy

✍ Luan, F.L. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 197 KB

High Incidence of Cytomegalovirus Diseas

✍ Sachin Gupta; Joshua D. Mitchell; David W. Markham; Pradeep P.A. Mammen; Parag C 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 92 KB

PUK16 COST-EFFECTIVENESS OF VALGANCICLOV

✍ C. Vicente; A. Humar; C. Lemieux; R. Zilbershtein; P. Douglas; L. Formica; C. Pi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB